tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IFRX Stock Latest News

Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment
Company AnnouncementsEdesa Biotech and InflaRx: Breathing New Life into ARDS Treatment
6d ago
EDSA
IFRX
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab
PremiumCompany Announcements
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab
6d ago
EDSA
IFRX
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Vilobelimab
PremiumCompany Announcements
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Vilobelimab
6d ago
EDSA
IFRX
JUST BREATHE: A New Hope for ARDS Treatment and Market Impact
PremiumCompany Announcements
JUST BREATHE: A New Hope for ARDS Treatment and Market Impact
6d ago
EDSA
IFRX
InflaRx’s Phase 2a Study on INF904: A Potential Game-Changer for Chronic Conditions
PremiumCompany Announcements
InflaRx’s Phase 2a Study on INF904: A Potential Game-Changer for Chronic Conditions
6d ago
IFRX
InflaRx Hold Rating: Balancing Strategic Opportunities and Market Uncertainties
PremiumRatingsInflaRx Hold Rating: Balancing Strategic Opportunities and Market Uncertainties
9d ago
IFRX
InflaRx Regains Nasdaq Compliance with Share Price Recovery
Premium
Company Announcements
InflaRx Regains Nasdaq Compliance with Share Price Recovery
2M ago
6K
IFRX
InflaRx regains compliance with Nasdaq min bid price requirement
Premium
The Fly
InflaRx regains compliance with Nasdaq min bid price requirement
2M ago
IFRX
InflaRx: Buy Rating Based on Promising C5a/C5aR Strategy and Strong Financial Position
PremiumRatings
InflaRx: Buy Rating Based on Promising C5a/C5aR Strategy and Strong Financial Position
2M ago
IFRX
InflaRx assumed with a Buy at H.C. Wainwright
PremiumThe Fly
InflaRx assumed with a Buy at H.C. Wainwright
2M ago
IFRX
InflaRx’s Hold Rating Amid Trial Delays and Uncertain Clinical Data
PremiumRatings
InflaRx’s Hold Rating Amid Trial Delays and Uncertain Clinical Data
3M ago
IFRX
InflaRx Reports Significant Losses in H1 2025 Financials
PremiumCompany Announcements
InflaRx Reports Significant Losses in H1 2025 Financials
3M ago
6K
IFRX
InflaRx reports Q2 EPS (21c) vs. (24c) last year
PremiumThe FlyInflaRx reports Q2 EPS (21c) vs. (24c) last year
3M ago
IFRX
InflaRx Receives Nasdaq Deficiency Notice for Share Price
Premium
Company Announcements
InflaRx Receives Nasdaq Deficiency Notice for Share Price
4M ago
6K
IFRX
InflaRx receives noncompliance notification from Nasdaq
Premium
The Fly
InflaRx receives noncompliance notification from Nasdaq
4M ago
IFRX
InflaRx Appoints KPMG as New Auditor Following Shareholder Approval
PremiumCompany Announcements
InflaRx Appoints KPMG as New Auditor Following Shareholder Approval
4M ago
6K
IFRX
InflaRx’s Strategic Shift to INF904: A Prudent Move with Promising Prospects
PremiumRatings
InflaRx’s Strategic Shift to INF904: A Prudent Move with Promising Prospects
5M ago
IFRX
InflaRx’s Strategic Shift to INF904: A Promising Focus Amidst Early-Stage Uncertainty
PremiumRatings
InflaRx’s Strategic Shift to INF904: A Promising Focus Amidst Early-Stage Uncertainty
5M ago
IFRX
InflaRx price target lowered to $3 from $6 at Oppenheimer
PremiumThe Fly
InflaRx price target lowered to $3 from $6 at Oppenheimer
5M ago
IFRX
InflaRx downgraded to Outperform from Strong Buy at Raymond James
PremiumThe FlyInflaRx downgraded to Outperform from Strong Buy at Raymond James
5M ago
IFRX
InflaRx Stock (IFRX) Plummets 55% on Clinical Failure
Premium
Market News
InflaRx Stock (IFRX) Plummets 55% on Clinical Failure
5M ago
IFRX
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
5M ago
M
KO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >